Univdatos Whatsapp
Aortic Valve Market

Global Aortic Valve Market is Expected to Foresee Significant Growth During the Forecast Period. Europe to Witness the Highest Growth

Global Aortic Valve Market is expected to grow significantly by 2027 expanding at a reasonable CAGR of around 13% during the forecast period (2021-2027). The aortic valve allows blood to flow in the right direction in the heart. It separates the main pump chamber of the heart (left ventricle) from the main arteries that supply the body with oxygen-rich blood (aorta). Each time the ventricle contracts, the aortic valve opens, allowing blood to flow from the left ventricle to the aorta. When the ventricles relax, the aortic valve closes and prevents blood from flowing back into the ventricles.

The global aortic valve market is experiencing significant growth on account of surging demand from patients and healthcare professionals across the globe owing to the rising prevalence of valvular diseases, initiatives are also being taken for creating awareness of valve replacement and increased focus on non-invasive surgical procedures. Moreover, the rapidly growing aging population across the globe is causing an increase in the number of patients having cardiovascular diseases and arteriosclerosis. Around 18 million Americans aged 20 and above have heart disease and nearly 650,000 Americans die of heart disease each year. Moreover, the most common cause of death is due to cardiovascular diseases is the narrowing or blockage of blood vessels. Also, around 85,000 vascular reconstruction surgeries are performed across the globe annually. Owing to these glaring statistics the demand for the aortic valve is anticipated to grow in the forthcoming years. Furthermore, the advancement in technology and various benefits associated with the use of aortic valves have also led to the growing adoption of the aortic valve market.

For a detailed analysis of the market drivers of aortic valve browse through – https://univdatos.com/report/aortic-valve-market/

Based on valve type, the market is bifurcated into tissue/biological type and mechanical type. The tissue/biological type segment grabbed a significant share of the global aortic valve market and will witness a considerable CAGR during the forecast period (2021-2027F) owing to various advantages associated with this type of valve such as avoiding lifelong warfarin therapy to prevent the formation of blood clots, long-term durability, and free from reoperation for valve degeneration.

Based on the suture type, the market is bifurcated into sutured and sutureless. The sutureless segment occupied a substantial share and is expected to grow at a significant CAGR during the forecast period 2021-2027 as it reduces the duration of cross-clamp and cardiopulmonary bypass (CPB) procedures compared to sutured valves.

Request for a Sample of the report browse through https://univdatos.com/get-a-free-sample-form-php/?product_id=20998

Additionally, the report provides detailed report also provides insights into the global aortic valve market according to the regions such as North America (United States, Canada, and the Rest of North America), Europe (Germany, France, Italy, Spain, United Kingdom, and Rest of Europe), Asia-Pacific (China, India, Australia, Japan, and Rest of APAC), Rest of World has been conducted. Europe dominated the market in 2020 owing to the well-established market players and increasing geriatric population in the region.

Boston Scientific Corporation, Edwards Lifesciences Corporation, CryoLife Inc., Medtronic plc, LivaNova PLC, Abbott Laboratories, JenaValve Technology Inc., Thubrikar Aortic Valve Inc., LifeNet Health Inc.,         Coroneo Inc. are some of the key players operating in the global aortic valve market. Several M&As along with partnerships have been undertaken by these players to develop new products.

Global Aortic Valve Market Segmentation

Market Insight, by Valve Type

  • Tissue/Biological
    • Mechanical

Market Insight, by Suture Type

  • Sutured
    • Sutureless

Market Insight, by Procedure

  • Open Surgery
  • Minimally Invasive Surgery

Market Insight, by End-Users

  • Hospitals
  • Ambulatory Surgical Centers

Market Insight, by Region

  • North America
    • United States
    • Canada
    • Rest of North America
  • Europe
    • France
    • Germany
    • Italy
    • Spain
    • United Kingdom
    • Rest of Europe
  • Asia-Pacific
    • China
    • India
    • Australia
    • Japan
    • Rest of Asia-Pacific
  • Rest of World

Top Company Profiles

  • Boston Scientific Corporation
  • Edwards Lifesciences Corporation
  • CryoLife Inc.
  • Medtronic plc
  • LivaNova PLC
  • Abbott Laboratories
  • JenaValve Technology Inc.
  • Thubrikar Aortic Valve Inc.
  • LifeNet Health Inc.
  • Coroneo Inc.

Leave A Comment

Select Language